Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer

Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer

J Thaddeus Beck Highlands Oncology Group, Fayetteville, AR, USA Abstract: Despite advances in cytotoxic chemotherapy and targeted therapies, 5-year ­survival rates remain low for patients with advanced breast cancer at diagnosis. This highlights the limited effectiveness of current treatme...

Full description

Bibliographic Details
Main Author: Beck JT
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:OncoTargets and Therapy
Subjects:
mammalian target of rapamycin
everolimus
hormone receptor–positive breast cancer
first-line
Online Access:https://www.dovepress.com/potential-role-for-mammalian-target-of-rapamycin-inhibitors-as-first-l-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/potential-role-for-mammalian-target-of-rapamycin-inhibitors-as-first-l-peer-reviewed-article-OTT

Similar Items